APA

Lim K. K., Yoon S. Y., Mohd Taib N. A., Shabaruddin F. H., Dahlui M., Woo Y. L., Thong M. K., Teo S. H. & Chaiyakunapruk N. (20190819). Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia. : Applied health economics and health policy.

Chicago

Lim Ka Keat, Yoon Sook Yee, Mohd Taib Nur Aishah, Shabaruddin Fatiha Hana, Dahlui Maznah, Woo Yin Ling, Thong Meow Keong, Teo Soo Hwang and Chaiyakunapruk Nathorn. 20190819. Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia. : Applied health economics and health policy.

Harvard

Lim K. K., Yoon S. Y., Mohd Taib N. A., Shabaruddin F. H., Dahlui M., Woo Y. L., Thong M. K., Teo S. H. and Chaiyakunapruk N. (20190819). Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia. : Applied health economics and health policy.

MLA

Lim Ka Keat, Yoon Sook Yee, Mohd Taib Nur Aishah, Shabaruddin Fatiha Hana, Dahlui Maznah, Woo Yin Ling, Thong Meow Keong, Teo Soo Hwang and Chaiyakunapruk Nathorn. Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia. : Applied health economics and health policy. 20190819.